Table 5.
Proportional cost of the patients with HAI relatively normal patient
| Year | 1 | 2 | 3 | 4 | 5 (3-4) | 6 (5/1) |
|---|---|---|---|---|---|---|
|
|
||||||
| Ni | Di | CSGK | [(A]Ni*ACTi) | RTCHE | RTCHE/Ni | |
| 2011 | 285 | 11,611 | 3,761,043 | 293,909 | 3,467,134 | 12,165.38 |
| 2012 | 213 | 6,901 | 1,133,483 | 417,346 | 716,137.2 | 3,362.15 |
| 2013 | 249 | 10,584 | 5,832,167 | 476,748 | 5,355,419 | 21,507.70 |
Note: Column 1 gives the number of the patients with HAIs; Column 2 provides the number of days of hospitalized the patients with HAIs, Column 3 presents the cost of the HAIs to SGK; Column 4 shows the total cost for the normal patients; Column 5 provides the proportional cost of the patients with HAIs to relatively normal patients and Column 6 gives the total treatment costs for patients with HAIs.